The manifestation of AIDS in Africa: An epidemiological overview

Journal of NeuroVirology

Volumn 11, Issue SUPPL. 1, 2005, Pages 50-57

  Ferrante, Pasquale ^a,b   Delbue, Serena ^b   Mancuso, Roberta ^b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Africa; AIDS; Epidemiology; HIV infection; Risk factors

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANEMIA; ANTIGEN DETECTION; BLOOD TRANSFUSION; CAUSE OF DEATH; CELLULAR IMMUNITY; CHILDHOOD DISEASE; CONDOM; CULTURAL FACTOR; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG ABUSE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MALARIA; MASS SCREENING; MORTALITY; MOTHER CHILD RELATION; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; REVIEW; SAFE SEX; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STRAIN DIFFERENCE; TUBERCULOSIS; VIRUS STRAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; CHILD; FEMALE; GEOGRAPHY; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; SOUTH AFRICA;

EID: 20844440543     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280590922955     Document Type: Review

References (60)

1. Agha S (2002). Declines in casual sex in Lusaka, Zambia: 1996-1999. AIDS 16: 291-293.
2. Bucher HC, Griffith LE, Fuyatt GH, Sudre P, Naef M, Sendi P, Battegay M (1999). Isoniazid prophylaxis for tubrtvulosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 13: 501-507.
3. Auvert B, Buve A, Ferry B, Carael M, Morison L, Lagarde E, Robinson NJ, Kahindo M, Chege J, Rutenberg N, Musonda R, Laourou M, Akam E, Study Group on the Heterogeneity of HIV Epidemics in African Cities (2001a). Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 15: S15-S30.
4. Auvert B, Buve A, Lagarde E, Kahindo M, Chege J, Rutenberg N, Musonda R, Laourou M, Akam E, Weiss HA, Study Group on the Heterogeneity of HIV Epidemics in African Cities (2001b). Male circumcision and HIV infection in four cities in sub-Saharan Africa. AIDS 15: S31-S40.
5. Bredell H, Williamson C, Sonnenberg P, Martin DJ, Morris L (1998). Genetic characterization of HIV type 1 from migrant workers in three South African gold mines. AIDS Res Hum Retroviruses 14: 677-684.
6. Bouvet E, De Vincenzi I, Ancelle R, Vachon F (1989). Defloration as risk factor for heterosexual HIV transmission. Lancet 1: 615.
7. Bucher HC, Griffith LE, Guyatt GH, Sudre P, Naef M, Sendi P, Battegay M (1999). Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 13: 501-507.
8. Buve A, Bishikwabo-Nsarhaza K, Mutangadura G (2002). The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 359: 2011-2017.
9. Buve A, Lagarde E, Carael M, Rutenberg N, Ferry B, Glynn JR, Laourou M, Akam E, Chege J, Sukwa T, Study Group on Heterogeneity of HIV Epidemics in African Cities (2001). Interpreting sexual behaviour data: validity issues in the multicentre study on factors determining the differential spread of HIV in four African cities. AIDS 15: S117-S126.
10. Carael M, Holmes KK (2001). Dynamics of HIV epidemics in sub-Saharan Africa: introduction. AIDS 15: S1-S4.
11. Chang LW, Osei-Kwasi M, Boakye D, Aidoo S, Hagy A, Curran JW, Vermund SH (2002). HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa. J Acquir Immune Defic Syndr 29: 511-516.
12. Churchyard GJ, Kleinschmidt I, Corbett EL, Mulder D, De Cock KM (1999). Mycobacterial disease in South African gold miners in the era of HIV infection. Int J Tuberc Lung Dis 3: 791-798.
13. Churchyard GJ, Kleinschmidt I, Corbett EL, Murray J, Smit J, De Cock KM (2000). Factors associated with an increased case-fatality rate in HIV-infected and noninfected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis 4: 705-712.
14. Corbett EL, Churchyard GJ, Charalambos S, Samb B, Moloi V, Clayton TC, Grant AD, Murray J, Hayes RJ, De Cock KM (2002a). Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 34: 1251-1258.
15. Corbett EL, Steketee RW, ter Kuile FO, Latif AS, Kamali A, Hayes RJ (2002b). HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 359: 2177-2187.
16. Cruciani M, Malena M, Bosco O, Gatti G, Serpelloni G (2001). The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clin Infect Dis 33: 1922-1930.
17. De Cock KM, Mbori-Ngacha D, Marum E (2002). Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet 360: 67-72.
18. Del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, Mabey D, Ross D, Grosskurth H, Hayes R (2002). Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 16: 451-462.
19. Denolf D, Musongela JP, Nzila N, Tahiri M, Colebunders R (2001). The HIV epidemic in Kinshasa, Democratic Republic of Congo. Int J STD AIDS 12: 832.
20. Engelbrecht S, Van Rensburg EJ (1995). Detection of southern African human immunodeficiency virus type 1 subtypes by polymerase chain reaction: evaluation of different primer pairs and conditions. J Virol Methods 55: 391-400.
21. Ferry B, Carael M, Buve A, Auvert B, Laourou M, Kanhonou L, de Loenzien M, Akam E, Chege J, Kaona F, Study Group on Heterogeneity of HIV Epidemics in African Cities (2001). Comparison of key parameters of sexual behaviour in four African urban populations with different levels of HIV infection. AIDS 15: S41-50.
22. Fleming DT, Wasserheit JN (1999). From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75: 3-17.
23. Francesconi P, Fabiani M, Dente MG, Lukwiya M, Okwey R, Ouma J, Ochakachon R, Cian F, Declich S (2001). HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS 15: 2445-2450.
24. French N, Gilks CF (2000). Fresh from the field: some controversies in tropical medicine and hygiene. HIV and malaria, do they interact? Trans R Soc Trop Med Hyg 94: 233-237.
25. Gallin MY, Adams AZ, Gbaguidi EA, Massougbodji A, Schmitz H, Erttman KD (1993). The prevalence of antibodies to HIV-1 and HIV-2 in onchocerciasis-endemic rural areas in southern Benin AIDS 7: 1534-1536.
26. Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G; Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA) (2000). Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14: 1985-1991.
27. Glynn JR, Buve A, Carael M, Musonda RM, Kahindo M, Macauley I, Tembo F, Zekeng L; Study Group on Heterogeneity of HIV Epidemics in African Cities (2001a). Factors influencing the difference in HIV prevalence between antenatal clinic and general population in sub-Saharan Africa. AIDS 15: 1717-1725.
28. Glynn JR, Carael M, Auvert B, Kahindo M, Chege J, Musonda R, Kaona F, Buve A; Study Group on the Heterogeneity of HIV Epidemics in African Cities (2001b). Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 15: S51-S60.
29. Gray RH, Wawer MJ, Sewankambo NK, Serwadda D, Li C, Moulton LH, Lutalo T, Wabwire-Mangen F, Meehan MP, Ahmed S, Paxton LA, Kiwanuka N, Nalugoda F, Korenromp EL, Quinn TC (1999). Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. AIDS 13: 2113-2123.
30. Hayes RJ, Schulz KF, Plummer FA (1995). The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg 98: 1-8.
31. Jones JL, Hanson DL, Dworkin MS, DeCock KM; Adult/Adolescent Spectrum of HIV Disease Group (2000). HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis 4: 1026-1031.
32. Kengeya-Kayondo JF, Malamba SS, Nunn AJ, Seeley JA, Ssali A, Mulder DW (1995). Human immunodeficiency virus (HIV-1) seropositivity among children in a rural population of south-west Uganda: probable routes of exposure. Ann Trop Paediatr 15: 115-120.
33. Lagarde E, Auvert B, Chege J, Sukwa T, Glynn JR, Weiss HA, Akam E, Laourou M, Carael M, Buve A; Study Group on the Heterogeneity of HIV Epidemics in African Cities (2001). Condom use and its association with HIV/sexually transmitted diseases in four urban communities of sub-Saharan Africa. AIDS 15: S71-78.
34. Lawn SD (2004). AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect 48: 1-12.
35. Leynaert B, Downs AM, De Vincenzi I, European Study Group on Heterosexual Transmission of HIV (1998). Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. Am J Epidemiol 148: 88-96.
36. Mallory KF, Churchyard GJ, Kleinschmidt I, De Cock KM, Corbett EL (2000). The impact of HIV infection on recurrence of tuberculosis in South African gold miners. Int J Tuberc Lung Dis 4: 455-462.
37. Meekers D, Calves AE (1997). 'Main' girlfriends, girlfriends, marriage, and money: the social context of HIV risk behaviour in sub-Saharan Africa. Health Transit Rev 7: 361-375.
38. Merlin M, Josse R, Trebucq A, Mouanda V, Kouka-Bemba D (1988). Surveillance epidemiologique du syndrome d'immunodepresiion acquise dans six etats d'Africa Centrale Med Trop 48: 381-389.
39. Moore A, Herrera G, Nyamongo J, Lackritz E, Granade T, Nahlen B, Oloo A, Opondo G, Muga R, Janssen R (2001). Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet 358: 657-660.
40. Morison L, Weiss HA, Buve A, Carael M, Abega SC, Kaona F, Kanhonou L, Chege J, Hayes RJ; Study Group on Heterogeneity of HIV Epidemics in African Cities (2001). Commercial sex and the spread of HIV in four cities in sub-Saharan Africa. AIDS 15: S61-S69.
41. Moses S, Bailey RC, Ronald AR (1998). Male circumcision: assessment of health benefits and risks. Sex Transm Infect 74: 368-373.
42. Ndung'u T, Renjifo B, Novitsky VA, McLane MF, Gaolekwe S, Essex M (2000). Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana Virology 278: 390-399.
43. Norrgren H, Andersson S, Biague AJ (2000). Trends and interaction of HIV-1 and HIV-2 in Guinea Bissau, west Africa: no protection of HIV-2 against HIV-1 infection. AIDS 14: 1276-1277.
44. Papathanasopoulos MA, Hunt GM, Tiemessen CT (2003). Evolution and diversity of HIV-1 in Africa: a review. Virus Genes 26: 151-163.
45. Peeters M, Sharp PM (2000). Genetic diversity of HIV-1: the moving target. AIDS 14: S129-S140.
46. Prazuck T, Yameogo JM, Heylinck B, Ouedraogo LT, Rochereau A, Guiard-Schmid JB, Lechuga P, Agranat P, Cot M, Malkin JE (1995). Mother-to-child transmission of human immunodeficiency virus type 1 and type 2 and dual infection: a cohort study in Banfora, Burkina Faso. Pediatr Infect Dis J 14: 940-947.
47. Royce RA, Sena A, Cates W Jr, Cohen MS (1997). Sexual transmission of HIV. N Engl J Med 336: 1072-1078.
48. Schmid G, Buve A, Calleja JG, Ghys PD, Boerma JT (2004). Unsafe injections and transmission of HIV-1 in sub-Saharan Africa. Lancet 363: 1649-1650.
49. Shisana O, Brookes H (2004). HSRC study of HIV/AIDS: National household HIV prevalence and risk survey of South African Children.
50. Shisana O, Simbayi L (2002). Nelson Mandela/HSRC study of HIV/AIDS: South African national HIV prevalence, behavioural risks and mass media. Household survey 2002.
51. Sibanda EN, Stanczuk G, Kasolo F, (2003). HIV/AIDS in Central Africa: pathogenesis, immunological and medical issues. Int Arch Allergy Immunol 132: 183-195.
52. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001 Nov 17;358(9294): 1687-93. Erratum in: Lancet 2002 Jun 15;359(9323): 2120.
53. UNAIDS. (2003). Report on the Global HIV/AIDS Epidemic 2003-Genev, 2003.
54. Van Eijk AM, Ayisi JG, ter Kuile FO, Misore A, Otieno JA, Kolczak MS, Kager PA, Steketee RW, Nahlen BL (2001). Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya. Am J Trop Med Hyg 65: 623-630.
55. Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L (2002). Genital shedding of herpes simplex virus among men. J Infect Dis 186: S34-S39.
56. Weiss HA, Quigley MA, Hayes RJ (2000). Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 14: 2361-2370.
57. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, Omoding N, Okongo M, Malamba S, Ojwiya A (2000). Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356: 1051-1056.
58. WHO (2001). Global prevalence and incidence of selected curable sexually transmitted infections: overview Geneva. WHO.
59. WHO (2002). HIV and AIDS epidemiological surveillance update for the WHO African regions.
60. Zaba B, Gregson S (1998). Measuring the impact of HIV on fertility in Africa. AIDS 12: S41-S50.